Plitidepsin: design, development, and potential place in therapy
Sara Alonso-Álvarez,1 Emilia Pardal,2 Diego Sánchez-Nieto,3 Miguel Navarro,4 Maria Dolores Caballero,1 Maria Victoria Mateos,1 Alejandro Martín1 1Hematology Department, IBSAL-CIC-USAL, Hospital Universitario de Salamanca, Salamanca, Spain; 2Hematology Department, Ho...
Main Authors: | Alonso-Álvarez S, Pardal E, Sánchez-Nieto D, Navarro M, Caballero MD, Mateos MV, Martín A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-01-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/plitidepsin-design-development-and-potential-place-in-therapy-peer-reviewed-article-DDDT |
Similar Items
-
c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity
by: Alberto Muñoz, et al.
Published: (2013-05-01) -
Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19
by: Michail Papapanou, et al.
Published: (2021-07-01) -
Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma
by: Patrick Schöffski, et al.
Published: (2009-03-01) -
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
by: María Victoria Mateos, et al.
Published: (2023-02-01) -
Marine-derived pipeline anticancer natural products: a review of their pharmacotherapeutic potential and molecular mechanisms
by: Mohamed Ali Seyed, et al.
Published: (2021-10-01)